Cite
HARVARD Citation
Swaminathan, M. et al. (2019). A phase 2 clinical trial of eltrombopag for treatment of patients with myelodysplastic syndromes after hypomethylating-agent failure. Leukemia & lymphoma. 60 (9), pp. 2207-2213. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Swaminathan, M. et al. (2019). A phase 2 clinical trial of eltrombopag for treatment of patients with myelodysplastic syndromes after hypomethylating-agent failure. Leukemia & lymphoma. 60 (9), pp. 2207-2213. [Online].